Lisata Therapeutics, Inc. (LSTA) shareholders
Close on Nov 17, 2026Market cap $9.37MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Branham Justin Earl | 462,149 | 5.10% | 13G (passive) | Aug 21, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of LSTA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 278,837 | 3.09% | $948.05K | +7,022 | 0.00% |
| Yakira Capital Management, Inc. | 138,561 | 1.54% | $471.11K | New | 0.13% |
| Css LLC/Il | 110,422 | 1.23% | $375.44K | +48,524 | 0.01% |
| Deltec Asset Management LLC | 83,197 | 0.92% | $282.87K | −6,803 | 0.04% |
| Rangeley Capital, LLC | 81,000 | 0.90% | $275.40K | +6,000 | 0.25% |
| Geode Capital Management, LLC | 72,632 | 0.81% | $247.00K | +1,745 | 0.00% |
| Virtu Financial LLC | 58,782 | 0.65% | $200.00K | +16,569 | 0.01% |
| BlackRock, Inc. | 54,857 | 0.61% | $186.51K | – | 0.00% |
| Vanguard Fiduciary Trust Co | 48,964 | 0.54% | $166.48K | +14,047 | 0.00% |
| Gts Securities LLC | 30,200 | 0.34% | $102.68K | −1,196 | 0.00% |
| State Street Corp | 25,348 | 0.28% | $86.18K | – | 0.00% |
| Jane Street Group, LLC | 18,741 | 0.21% | $63.72K | New | 0.00% |
| Citadel Advisors LLC | 15,541 | 0.17% | $52.84K | −7,125 | 0.00% |
| Northern Trust Corp | 15,534 | 0.17% | $52.82K | +5,266 | 0.00% |
| JBF Capital, Inc. | 14,347 | 0.16% | $48.78K | +1,113 | 0.01% |
| Cerity Partners LLC | 12,183 | 0.14% | $41.42K | – | 0.00% |
| Bank Of America Corp /De/ | 10,353 | 0.11% | $35.20K | – | 0.00% |
| HighTower Advisors, LLC | 10,042 | 0.11% | $34.14K | – | 0.00% |
| International Assets Investment Management, LLC | 5,000 | 0.06% | $16.80K | – | 0.00% |
| Founders Capital Management | 1,667 | 0.02% | $5.67K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 31 | 1M | 12.1% | 3 / 9 | 5 / 5 | 0M | 0M |
| Q1 2026 | 33 | 1M | 11.6% | 13 / 5 | 3 / 4 | 1M | 0M |
| Q4 2025 | 25 | 1M | 7.9% | 6 / 7 | 6 / 2 | 0M | 0M |
| Q3 2025 | 21 | 1M | 8.2% | 3 / 5 | 5 / 2 | 0M | 0M |
| Q2 2025 | 20 | 1M | 8.7% | 2 / 6 | 3 / 4 | 0M | 0M |
| Q1 2025 | 22 | 1M | 8.7% | 3 / 6 | 5 / 2 | 0M | 0M |
| Q4 2024 | 21 | 1M | 8.7% | 2 / 4 | 4 / 1 | 0M | 0M |
| Q3 2024 | 20 | 1M | 8.5% | 2 / 7 | 4 / 3 | 0M | 0M |
| Q2 2024 | 22 | 1M | 8.3% | 2 / 7 | 3 / 1 | 0M | 0M |
| Q1 2024 | 21 | 1M | 8.3% | 1 / 7 | 5 / 2 | 0M | 0M |
| Q4 2023 | 22 | 1M | 8.3% | 2 / 7 | 5 / 1 | 0M | 0M |
| Q3 2023 | 21 | 1M | 7.6% | 3 / 8 | 2 / 4 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
10 funds held LSTA in Q2 2026, 81% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of LSTA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 191,371 | 2.12% | $650.66K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 80,444 | 0.89% | $273.51K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 39,003 | 0.43% | $126.76K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 10,373 | 0.12% | $33.71K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 7,022 | 0.08% | $23.87K | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 4,379 | 0.05% | $14.23K | 0.00% | May 31, 2026 |
| U.S. Social Core Equity 2 Portfolio | 2,185 | 0.02% | $2.16K | 0.00% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 2,010 | 0.02% | $6.53K | 0.00% | May 31, 2026 |
| Dimensional US Sustainability Core 1 ETF | 100 | 0.00% | $99 | 0.00% | Jul 31, 2026 |
| Dimensional US Core Equity 1 ETF | 8 | 0.00% | $8 | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David J. Mazzo | President & CEO, Director | 352,986 | 3.92% | Jan 13, 2026 |
| Joshua Lehrer-Graiwer | President & COO | 27,808 | 0.31% | Sep 28, 2026 |
| Kristen K. Buck | EVP, R&D and CMO | 95,609 | 1.06% | Jan 13, 2026 |
| Tariq Imam | SVP, Bus Dev, General Counsel | 36,591 | 0.41% | Jan 13, 2026 |
| James Nisco | SVP, Fin/Treas, Chief Actg Off | 32,311 | 0.36% | Jan 13, 2026 |
| Jeffrey S. Farrow | Director | 0 | – | Oct 15, 2026 |
| Ted W. Love | Director | 19,260 | 0.21% | Sep 28, 2026 |
| Mohammad Azab | Director | 104,925 | 1.16% | Jan 13, 2026 |
| Gregory B. Brown | Director | 95,659 | 1.06% | Jan 13, 2026 |
| Cynthia Louise Flowers | Director | 95,446 | 1.06% | Jan 13, 2026 |
| Steven M. Klosk | Director | 95,815 | 1.06% | Jan 13, 2026 |
| Heidi Henson | Director | 85,725 | 0.95% | Jan 13, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| James Nisco SVP, Fin/Treas, Chief Actg Off | Jan 9, 2026 | Tax withholding | −781 | $1.97 | $1.54K | 32,311 |
| James Nisco SVP, Fin/Treas, Chief Actg Off | Jan 9, 2026 | Award | +15,000 | – | – | 38,491 |
| James Nisco SVP, Fin/Treas, Chief Actg Off | Jan 9, 2026 | Tax withholding | −2,131 | $1.97 | $4.20K | 36,360 |
| James Nisco SVP, Fin/Treas, Chief Actg Off | Jan 9, 2026 | Tax withholding | −2,131 | $1.97 | $4.20K | 34,229 |
| James Nisco SVP, Fin/Treas, Chief Actg Off | Jan 9, 2026 | Tax withholding | −1,137 | $1.97 | $2.24K | 33,092 |
| Tariq Imam SVP, Bus Dev, General Counsel | Jan 9, 2026 | Tax withholding | −747 | $1.97 | $1.47K | 36,591 |
| Tariq Imam SVP, Bus Dev, General Counsel | Jan 9, 2026 | Award | +15,000 | – | – | 39,579 |
| Tariq Imam SVP, Bus Dev, General Counsel | Jan 9, 2026 | Tax withholding | −1,401 | $1.97 | $2.76K | 38,178 |
| Tariq Imam SVP, Bus Dev, General Counsel | Jan 9, 2026 | Tax withholding | −840 | $1.97 | $1.65K | 37,338 |
| Tariq Imam SVP, Bus Dev, General Counsel | Jan 9, 2026 | Tax withholding | −513 | $1.97 | $1.01K | 36,078 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2026 | Tax withholding | −3,221 | $1.97 | $6.35K | 95,609 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2026 | Tax withholding | −2,982 | $1.97 | $5.87K | 98,830 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2026 | Tax withholding | −2,147 | $1.97 | $4.23K | 93,462 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2026 | Award | +25,000 | – | – | 104,794 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2026 | Tax withholding | −2,982 | $1.97 | $5.87K | 101,812 |
| Cynthia Louise Flowers Director | Jan 9, 2026 | Award | +30,456 | – | – | 95,446 |
| Heidi Henson Director | Jan 9, 2026 | Award | +30,456 | – | – | 85,725 |
| Mohammad Azab Director | Jan 9, 2026 | Award | +30,456 | – | – | 104,925 |
| David J. Mazzo President & CEO, Director | Jan 9, 2026 | Award | +81,000 | – | – | 352,986 |
| David J. Mazzo President & CEO, Director | Jan 9, 2026 | Tax withholding | −10,503 | $1.97 | $20.69K | 342,483 |
| David J. Mazzo President & CEO, Director | Jan 9, 2026 | Tax withholding | −10,515 | $1.97 | $20.71K | 331,968 |
| David J. Mazzo President & CEO, Director | Jan 9, 2026 | Tax withholding | −7,854 | $1.97 | $15.47K | 311,890 |
| David J. Mazzo President & CEO, Director | Jan 9, 2026 | Tax withholding | −12,224 | $1.97 | $24.08K | 319,744 |
| Gregory B. Brown Director | Jan 9, 2026 | Award | +30,456 | – | – | 95,659 |
| Steven M. Klosk Director | Jan 9, 2026 | Award | +30,456 | – | – | 95,815 |
| James Nisco SVP, Fin/Treas, Chief Actg Off | Jan 10, 2025 | Tax withholding | −416 | $3.73 | $1.55K | 23,491 |
| David J. Mazzo President & CEO, Director | Jan 10, 2025 | Tax withholding | −3,106 | $3.73 | $11.59K | 264,690 |
| Kristen K. Buck EVP, R&D and CMO | Jan 10, 2025 | Tax withholding | −456 | $3.73 | $1.70K | 79,794 |
| Mohammad Azab Director | Jan 9, 2025 | Award | +15,789 | – | – | 74,469 |
| James Nisco SVP, Fin/Treas, Chief Actg Off | Jan 9, 2025 | Tax withholding | −1,137 | $3.80 | $4.32K | 24,688 |
| James Nisco SVP, Fin/Treas, Chief Actg Off | Jan 9, 2025 | Tax withholding | −781 | $3.80 | $2.97K | 23,907 |
| James Nisco SVP, Fin/Treas, Chief Actg Off | Jan 9, 2025 | Tax withholding | −2,131 | $3.80 | $8.10K | 25,825 |
| James Nisco SVP, Fin/Treas, Chief Actg Off | Jan 9, 2025 | Award | +15,000 | – | – | 27,956 |
| Gregory B. Brown Director | Jan 9, 2025 | Award | +15,789 | – | – | 65,203 |
| Steven M. Klosk Director | Jan 9, 2025 | Award | +15,789 | – | – | 65,359 |
| Heidi Henson Director | Jan 9, 2025 | Award | +15,789 | – | – | 55,269 |
| Cynthia Louise Flowers Director | Jan 9, 2025 | Award | +15,789 | – | – | 64,990 |
| David J. Mazzo President & CEO, Director | Jan 9, 2025 | Tax withholding | −9,414 | $3.80 | $35.77K | 285,738 |
| David J. Mazzo President & CEO, Director | Jan 9, 2025 | Tax withholding | −10,925 | $3.80 | $41.52K | 274,813 |
| David J. Mazzo President & CEO, Director | Jan 9, 2025 | Tax withholding | −7,017 | $3.80 | $26.66K | 267,796 |
| David J. Mazzo President & CEO, Director | Jan 9, 2025 | Award | +81,000 | – | – | 295,152 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2025 | Tax withholding | −2,863 | $3.80 | $10.88K | 82,158 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2025 | Tax withholding | −1,908 | $3.80 | $7.25K | 80,250 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2025 | Award | +25,000 | – | – | 87,672 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2025 | Tax withholding | −2,651 | $3.80 | $10.07K | 85,021 |
| David J. Mazzo President & CEO, Director | Oct 1, 2024 | Tax withholding | −26,964 | $2.93 | $79.00K | 211,834 |
| David J. Mazzo President & CEO, Director | Oct 1, 2024 | Award | +58,000 | $2.93 | $169.94K | 238,798 |
| James Nisco SVP, Fin/Treas, Chief Actg Off | Oct 1, 2024 | Award | +3,300 | $2.93 | $9.67K | 14,657 |
| James Nisco SVP, Fin/Treas, Chief Actg Off | Oct 1, 2024 | Tax withholding | −1,701 | $2.93 | $4.98K | 12,956 |
| Kristen K. Buck EVP, R&D and CMO | Oct 1, 2024 | Award | +15,000 | $2.93 | $43.95K | 69,035 |
| Kristen K. Buck EVP, R&D and CMO | Oct 1, 2024 | Tax withholding | −6,363 | $2.93 | $18.64K | 62,672 |
| David J. Mazzo Chief Executive Officer, Director | Jan 11, 2024 | Tax withholding | −1,026 | $2.99 | $3.07K | 174,766 |
| Kristen K. Buck EVP, R&D and CMO | Jan 10, 2024 | Tax withholding | −512 | $3.00 | $1.54K | 54,035 |
| David J. Mazzo Chief Executive Officer, Director | Jan 10, 2024 | Tax withholding | −3,470 | $3.00 | $10.41K | 175,792 |
| Mohammad Azab Director | Jan 9, 2024 | Award | +19,480 | – | – | 58,680 |
| Steven M. Klosk Director | Jan 9, 2024 | Award | +19,480 | – | – | 49,570 |
| Gregory B. Brown Director | Jan 9, 2024 | Award | +19,480 | – | – | 49,414 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2024 | Tax withholding | −2,147 | $3.08 | $6.61K | 54,547 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2024 | Award | +27,000 | – | – | 59,915 |
| Kristen K. Buck EVP, R&D and CMO | Jan 9, 2024 | Tax withholding | −3,221 | $3.08 | $9.92K | 56,694 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Lisata Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 18,139 shares on Aug 24, 2026 over the last 90 days.
See a number that looks wrong?